Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2013, Article ID 561016, 7 pages
http://dx.doi.org/10.1155/2013/561016
Research Article

Adipocytokine Associations with Insulin Resistance in British South Asians

1Department of Cardiovascular Sciences, University of Leicester, Leicester LE3 9QP, UK
2Leicester Diabetes Center, Leicester General Hospital, Ward 5 (Broadleaf), Gwendolen Road, Leicester LE5 4PW, UK
3Department of Health Sciences, University of Leicester, Leicester LE1 6TP, UK
4Buckinghamshire Hospitals NHS Trust, Buckinghamshire HP7 OJD, UK

Received 16 August 2012; Accepted 17 December 2012

Academic Editor: N. Sattar

Copyright © 2013 D. R. Webb et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. E. Scherer, S. Williams, M. Fogliano, G. Baldini, and H. F. Lodish, “A novel serum protein similar to C1q, produced exclusively in adipocytes,” The Journal of Biological Chemistry, vol. 270, no. 45, pp. 26746–26749, 1995. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Haluzik, J. Parizkova, and M. M. Haluzik, “Adiponectin and its role in the obesity-induced insulin resistance and related complications,” Physiology Research, vol. 53, no. 2, pp. 123–129, 2004. View at Google Scholar
  3. N. Stefan and M. Stumvoll, “Adiponectin: its role in metabolism and beyond,” Hormone and Metabolic Research, vol. 34, no. 9, pp. 469–474, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Li, H. J. Shin, E. L. Ding, and R. M. van Dam, “Adiponectin levels and risk of type 2 diabetes. A systematic review and meta-analysis,” The Journal of the American Medical Association, vol. 302, no. 2, pp. 179–188, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Lindsay, T. Funahashi, R. L. Hanson et al., “Adiponectin and development of type 2 diabetes in the Pima Indian population,” The Lancet, vol. 360, no. 9326, pp. 57–58, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. G. Wannamethee, G. D. O. Lowe, A. Rumley, L. Cherry, P. H. Whincup, and N. Sattar, “Adipokines and risk of type 2 diabetes in older men,” Diabetes Care, vol. 30, no. 5, pp. 1200–1205, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. B. Bayés, M. L. Granada, M. C. Pastor et al., “Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation,” American Journal of Transplantation, vol. 7, no. 2, pp. 416–422, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Snehalatha, B. Mukesh, M. Simon, V. Viswanathan, S. M. Haffner, and A. Ramachandran, “Plasma adiponectin is an independent predictor of type 2 diabetes in Asian Indians,” Diabetes Care, vol. 26, no. 12, pp. 3226–3229, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. M. B. Snijder, R. J. Heine, J. C. Seidell et al., “Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the Hoorn study,” Diabetes Care, vol. 29, no. 11, pp. 2498–2503, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. W. Koenig, N. Khuseyinova, J. Baumert, C. Meisinger, and H. Löwel, “Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from Southern Germany,” Journal of the American College of Cardiology, vol. 48, no. 7, pp. 1369–1377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. J. Spranger, A. Kroke, M. Möhlig et al., “Adiponectin and protection against type 2 diabetes mellitus,” The Lancet, vol. 361, no. 9353, pp. 226–228, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Knobler, M. Benderly, V. Boyko et al., “Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose,” European Journal of Endocrinology, vol. 154, no. 1, pp. 87–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. M. Choi, J. Lee, K. W. Lee et al., “Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans,” Clinical Endocrinology, vol. 61, no. 1, pp. 75–80, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Daimon, T. Oizumi, T. Saitoh et al., “Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese population: the Funagata study,” Diabetes Care, vol. 26, no. 7, pp. 2015–2020, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Nakashima, N. Kamei, K. Yamane, S. Nakanishi, A. Nakashima, and N. Kohno, “Decreased total and high molecular weight adiponectin are independent risk factors for the development of type 2 diabetes in Japanese-Americans,” Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 10, pp. 3873–3877, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Rabe, M. Lehrke, K. G. Parhofer, and U. C. Broedl, “Adipokines and insulin resistance,” Molecular Medicine, vol. 14, no. 11-12, pp. 741–751, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Sattar, S. G. Wannamethee, and N. G. Forouhi, “Novel biochemical risk factors for type 2 diabetes—pathogenic insights or prediction possibilities?” Diabetologia, vol. 51, no. 6, pp. 926–940, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P. H. Whincup, J. A. Gilg, O. Papacosta et al., “Early evidence of ethnic differences in cardiovascular risk: cross-sectional comparison of British South Asian and white children,” British Medical Journal, vol. 324, no. 7338, pp. 635–638, 2002. View at Google Scholar · View at Scopus
  19. N. Abate, M. Chandalia, P. G. Snell, and S. M. Grundy, “Adipose tissue metabolites and insulin resistance in non-diabetic Asian Indian men,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 6, pp. 2750–2755, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Valsamakis, R. Chetty, P. G. McTernan, N. M. Al-Daghri, A. H. Barnett, and S. Kumar, “Fasting serum adiponectin concentration is reduced in Indo-Asian subjects and is related to HDL cholesterol,” Diabetes, Obesity and Metabolism, vol. 5, no. 2, pp. 131–135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Martin, L. P. Palaniappan, A. C. Kwan, G. M. Reaven, and P. D. Reaven, “Ethnic differences in the relationship between adiponectin and insulin sensitivity in South Asian and Caucasian women,” Diabetes Care, vol. 31, no. 4, pp. 798–801, 2008. View at Google Scholar
  22. A. Raji, M. D. Gerhard-Herman, M. Warren et al., “Insulin resistance and vascular dysfunction in nondiabetic Asian Indians,” Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 8, pp. 3965–3972, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. W. F. Ferris, N. H. Naran, N. J. Crowther, P. Rheeder, L. van der Merwe, and N. Chetty, “The relationship between insulin sensitivity and serum adiponectin levels in three population groups,” Hormone and Metabolic Research, vol. 37, no. 11, pp. 695–701, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Wasim, N. M. Al-Daghri, R. Chetty, P. G. McTernan, A. H. Barnett, and S. Kumar, “Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians,” Cardiovascular Diabetology, vol. 5, article 10, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Mente, F. Razak, S. Blankenberg et al., “Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance,” Diabetes Care, vol. 33, no. 7, pp. 1629–1634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Luo, R. Oza-Frank, V. Mohan, K. M. Narayan, and K. Gokulakrishnan, “Serum total adiponectin is associated with impaired glucose tolerance in Asian Indian females but not in males,” Journal of Diabetes Science and Technology, vol. 4, no. 3, pp. 645–651, 2010. View at Google Scholar · View at Scopus
  27. N. Bansal, S. G. Anderson, A. Vyas et al., “Adiponectin and lipid profiles compared with insulins in relation to early growth of British South Asian and European children: the manchester children's growth and vascular health study,” Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 8, pp. 2567–2574, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Snehalatha, A. Yamuna, and A. Ramachandran, “Plasma adiponectin does not correlate with insulin resistance and cardiometabolic variables in non-diabetic Asian Indian teenagers,” Diabetes Care, vol. 31, no. 12, pp. 2374–2379, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. L. J. Gray, J. R. Tringham, M. J. Davies et al., “Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study,” Vascular Health and Risk Management, vol. 6, pp. 837–842, 2010. View at Google Scholar · View at Scopus
  30. World Health Organization: Definition, Diagnosis, and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus, World Health Organization, Geneva, Switzerland, 1999.
  31. K. Khunti, N. Taub, D. R. Webb et al., “Validity of self-assessed waist circumference in a multi-ethnic UK population,” Diabetic Medicine, vol. 29, no. 3, pp. 404–409, 2012. View at Publisher · View at Google Scholar
  32. N. Zhu, J. S. Pankow, C. M. Ballantyne et al., “High-molecular-weight adiponectin and the risk of type 2 diabetes in the ARIC study,” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 11, pp. 5097–5104, 2010. View at Publisher · View at Google Scholar
  33. V. Mohan, R. Deepa, R. Pradeepa et al., “Association of low adiponectin levels with the metabolic syndrome —the Chennai Urban Rural Epidemiology study (CURES-4),” Metabolism, vol. 54, no. 4, pp. 476–481, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Retnakaran, Y. Qi, P. W. Connelly, M. Sermer, A. J. Hanley, and B. Zinman, “Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta-cell dysfunction and fasting glycaemia,” Diabetologia, vol. 53, no. 2, pp. 268–276, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Drapeau, É. Doucet, R. Rabasa-Lhoret, M. Brochu, D. Prud'homme, and P. Imbeault, “Improvement in insulin sensitivity by weight loss does not affect hyperinsulinemia-mediated reduction in total and high molecular weight adiponectin: a MONET study,” Applied Physiology, Nutrition and Metabolism, vol. 36, no. 2, pp. 191–200, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. J. R. Cook and R. K. Semple, “Hypoadiponectinemia—cause or consequence of human “insulin resistance”?” Journal of Clinical Endocrinology and Metabolism, vol. 95, no. 4, pp. 1544–1554, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. J. S. Yudkin, C. S. Yajnik, V. Mohamed-Ali, and K. Bulmer, “High levels of circulating pro-inflammatory cytokines and leptin in urban, but not rural, Indians. A potential explanation for increased risk of diabetes and coronary heart disease,” Diabetes Care, vol. 22, no. 2, pp. 363–364, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. M. A. Banerji, N. Faridi, R. Atluri, R. L. Chaiken, and H. E. Lebovitz, “Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 1, pp. 137–144, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. G. S. Hotamisligil and B. M. Spiegelman, “Tumor necrosis factor α: a key component of the obesity-diabetes link,” Diabetes, vol. 43, no. 11, pp. 1271–1278, 1994. View at Google Scholar · View at Scopus
  40. Y. Wang, K. S. L. Lam, M. H. Yau, and A. Xu, “Post-translational modifications of adiponectin: mechanisms and functional implications,” Biochemical Journal, vol. 409, no. 3, pp. 623–633, 2008. View at Publisher · View at Google Scholar · View at Scopus